Europe
Asia
Oceania
Americas
Africa
Slough
Reckitt’s headache: Consumer goods giant Reckitt Be
CITY
In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan
Companies in the news and how they were assessed
UK equities are having their time in the sun. The FTSE 100 recently hit an all-time high of 9,000, driven by a broad recovery in equity prices. To put it another way, the rally wasn’t just driven by a
